https://european-biotechnology.net/wp-content/uploads/2024/10/Astellas-Gene-Therapy-Centra-in-South-San-Francisco-1030x693-1.jpg
693
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-09 05:45:482024-10-09 05:45:48AviadoBio Ltd inks US$2.2bn gene therapy deal with Astellas Pharma Inc
https://european-biotechnology.net/wp-content/uploads/2024/10/lung-freepik-ai-20241008-1030x579-1.jpeg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-08 12:45:282024-10-08 12:45:28Vicore secures funding to accelerate drug development
https://european-biotechnology.net/wp-content/uploads/2024/10/fabentech-hera-loan-20241008-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-08 06:58:382024-10-08 06:58:38€20m loan for pandemic preparedness
https://european-biotechnology.net/wp-content/uploads/2024/10/Scotland-1030x618-1.jpg
618
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-03 07:25:302024-10-03 07:25:30Kurma closes new fund at €250m
https://european-biotechnology.net/wp-content/uploads/2024/10/Regor-1030x495-1.png
495
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-01 11:06:532024-10-01 11:06:53Genentech takes over Regor’s RGT-419B for US$850m upfront
https://european-biotechnology.net/wp-content/uploads/2024/10/SPIMA-e1727778052587.png
319
566
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-01 10:21:532024-10-01 10:21:53Spima Therapeutics starts with global licence agreement
https://european-biotechnology.net/wp-content/uploads/2024/10/EFSA-Gourmey-1030x824-1.png
824
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-01 10:11:542024-10-01 14:02:02EFSA updates guidelines on cultured proteins and Novel Food
https://european-biotechnology.net/wp-content/uploads/2024/09/LevinJM_Headshot_FINAL_20161028-1030x677-1.jpg
677
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-30 04:00:172024-09-30 04:00:17Long version of The BIOSECURE Act: The West’s Wake-Up Call to China’s Biotech Dominance
https://european-biotechnology.net/wp-content/uploads/2024/09/Asabys-management-team_©-Asabys-Partners-e1727419179308-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-27 06:40:262024-09-27 06:40:26Asabys Partners close €180m Sabadell Asabys II Fund
https://european-biotechnology.net/wp-content/uploads/2024/09/Alessio-Cantore-e1727256487625.jpg
242
430
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-25 09:33:552024-09-25 09:33:55Genespire raises US$52m in Series B round
Scroll to top
